124 related articles for article (PubMed ID: 6748797)
21. Donor screening for hepatitis B virus infection in a cell and tissue bank.
Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
[TBL] [Abstract][Full Text] [Related]
22. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
Chung HT; Lee JS; Lok AS
Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
[TBL] [Abstract][Full Text] [Related]
23. [A solid-phase double-sandwich ELISA for detecting anti-HBc IgM].
Xu ZY
Zhonghua Liu Xing Bing Xue Za Zhi; 1984 Jun; 5(3):176-9. PubMed ID: 6518487
[No Abstract] [Full Text] [Related]
24. [Evaluation of Anti HBc RIA Kit (CORAB) (author's transl)].
Kanamori I; Nakano S; Higuchi C; Kunieda Y; Tsuruta H; Kimura T; Ichikawa H
Radioisotopes; 1980 Aug; 29(8):395-7. PubMed ID: 7208998
[No Abstract] [Full Text] [Related]
25. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen.
Marusawa H; Uemoto S; Hijikata M; Ueda Y; Tanaka K; Shimotohno K; Chiba T
Hepatology; 2000 Feb; 31(2):488-95. PubMed ID: 10655275
[TBL] [Abstract][Full Text] [Related]
26. Isolated presence of antibody to hepatitis B core antigen in injection drug users: do they need to be vaccinated?
Quaglio G; Lugoboni F; Vento S; Lechi A; Accordini A; Bossi C; Faccini M; Mecenero V; Pani A; Pantalena M; Residori M; Mezzelani P
Clin Infect Dis; 2001 May; 32(10):E143-4. PubMed ID: 11317267
[TBL] [Abstract][Full Text] [Related]
27. Missed opportunities: ALT and anti-HBc as surrogate tests for hepatitis.
Bettigole R; Shastri KA
J Med; 1997; 28(5-6):363-9. PubMed ID: 9604794
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus transmitted by HBsAg-negative blood containing anti-HBc.
Hopkins R; Kane E; Robertson AE; Haase G
Med Lab Sci; 1982 Jan; 39(1):61-2. PubMed ID: 7098783
[No Abstract] [Full Text] [Related]
29. Impact of a policy to permit the return of donors repeat-reactive to the Abbott PRISM antibody to hepatitis B core antigen assay.
O'Brien SF; Yi QL; Fan W; Fearon MA; Scalia V; Goldman M
Transfusion; 2009 Feb; 49(2):271-7. PubMed ID: 19389210
[TBL] [Abstract][Full Text] [Related]
30. [The efficacy of the prevaccinal detection of anti-HBc in hepatitis B vaccination programs].
Guarga Rojas A; Grifell Martín E
Med Clin (Barc); 1993 Nov; 101(17):679. PubMed ID: 8289519
[No Abstract] [Full Text] [Related]
31. [Etiological study on chronic and post-transfusion hepatitis].
Cao HL
Zhonghua Nei Ke Za Zhi; 1984 Jan; 23(1):19-21, 62. PubMed ID: 6525899
[No Abstract] [Full Text] [Related]
32. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C
J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901
[TBL] [Abstract][Full Text] [Related]
33. Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients.
Neau D; Winnock M; Galpérine T; Jouvencel AC; Castéra L; Legrand E; Tranchant E; Balestre E; Lacoste D; Ragnaud JM; Dupon M; Lafon ME; Dabis F;
HIV Med; 2004 May; 5(3):171-3. PubMed ID: 15139983
[TBL] [Abstract][Full Text] [Related]
34. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).
Yen YH; Chen CH; Wang JH; Lee CM; Changchien CS; Lu SN
Liver Int; 2005 Dec; 25(6):1162-8. PubMed ID: 16343067
[TBL] [Abstract][Full Text] [Related]
35. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan.
Liu CJ; Lo SC; Kao JH; Tseng PT; Lai MY; Ni YH; Yeh SH; Chen PJ; Chen DS
J Hepatol; 2006 Jan; 44(1):39-46. PubMed ID: 16168517
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of hepatitis C virus antibody in patients on chronic hemodialysis.
Nomiyama K; Tsuji H; Ikeda K; Kawatoko T; Kashiwagi S; Nakamura S; Fujishima M
Fukuoka Igaku Zasshi; 1998 Aug; 89(8):232-7. PubMed ID: 9778915
[TBL] [Abstract][Full Text] [Related]
37. [Incidence of antibody against hepatitis B core antigen (anti-HBc) in chronic diffuse liver diseases].
Dávid K; Halmy L
Orv Hetil; 1983 Apr; 124(15):879-84. PubMed ID: 6856288
[No Abstract] [Full Text] [Related]
38. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
Manzini P; Girotto M; Borsotti R; Giachino O; Guaschino R; Lanteri M; Testa D; Ghiazza P; Vacchini M; Danielle F; Pizzi A; Valpreda C; Castagno F; Curti F; Magistroni P; Abate ML; Smedile A; Rizzetto M
Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990
[TBL] [Abstract][Full Text] [Related]
39. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
[TBL] [Abstract][Full Text] [Related]
40. Suitability of yeast- and Escherichia coli-expressed hepatitis B virus core antigen derivatives for detection of anti-HBc antibodies in human sera.
Li ZX; Hong GQ; Hu B; Liang MJ; Xu J; Li L
Protein Expr Purif; 2007 Dec; 56(2):293-300. PubMed ID: 17897838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
